ViewsML
PrivateLast Round
Seed
Apr 20, 2026
Total Funding Raised
$3.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ViewsML is a healthcare IT company that has developed an AI-powered platform and virtual biomarker library to generate per-cell biomarker spatial insights from standard pathology images, eliminating the need for physical laboratory staining.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Drug Discovery, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViewsML Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ViewsML Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 20, 2026 | ||||
| Seed | Apr 1, 2024 |
ViewsML Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WUTIF Management Corporation | Seed |
| Defined | Seed |
| RiSC Capital | Seed |
| Wittington Ventures | Seed |
| Continuum Health Ventures | Seed |
| SFU VentureLabs | Seed |
| efund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
$3.5M raised in Seed round.
- Feb 2, 2026
Monthly visitors grew 240% MoM, from 454 to 1.5K.
ViewsML Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViewsML's valuation, stock price, and market status.